Literature DB >> 8132210

Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.

W Zhang1, P J Lachmann.   

Abstract

To investigate the effect of carbohydrate on activation of the alternative pathway of complement by IgA immune complexes, aglycosylated monoclonal IgA was made biosynthetically in the presence of tunicamycin. When immune complexes were incubated with normal human serum (NHS), the aglycosylated IgA immune complexes caused less depletion of the alternative pathway activity of the serum. They also bound less C3 and produced less terminal complement complexes. The binding of C3 to both immune complexes was mainly through hydroxylamine sensitive ester bonds. C3 did not bind to free IgA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132210      PMCID: PMC1422296     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.

Authors:  Y M Lucisano Valim; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

Review 3.  IgG galactosylation--its biological significance and pathology.

Authors:  K Furukawa; A Kobata
Journal:  Mol Immunol       Date:  1991-12       Impact factor: 4.407

4.  The binding site for C1q on IgG.

Authors:  A R Duncan; G Winter
Journal:  Nature       Date:  1988-04-21       Impact factor: 49.962

Review 5.  Immunoglobulin G: functional sites.

Authors:  D R Burton
Journal:  Mol Immunol       Date:  1985-03       Impact factor: 4.407

6.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

7.  Human IgD and IgA1 compete for D-galactose-related binding sites on the lectin jacalin.

Authors:  B D Zehr; S D Litwin
Journal:  Scand J Immunol       Date:  1987-09       Impact factor: 3.487

8.  Localization of the human complement component C3 binding site on the IgG heavy chain.

Authors:  J M Shohet; L Bergamaschini; A E Davis; M C Carroll
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

9.  Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors.

Authors:  M R Walker; J Lund; K M Thompson; R Jefferis
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

10.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

Authors:  M Brüggemann; G T Williams; C I Bindon; M R Clark; M R Walker; R Jefferis; H Waldmann; M S Neuberger
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  21 in total

1.  Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Authors:  Michelle M Gomes; Hitoshi Suzuki; Monica T Brooks; Milan Tomana; Zina Moldoveanu; Jiri Mestecky; Bruce A Julian; Jan Novak; Andrew B Herr
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

2.  Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).

Authors:  Robert J Boackle; Quang L Nguyen; Renata S Leite; Xiaofeng Yang; Jana Vesely
Journal:  Mol Immunol       Date:  2005-03-05       Impact factor: 4.407

Review 3.  IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.

Authors:  Jing Xue; Li-Ping Zhu; Qiang Wei
Journal:  Glycoconj J       Date:  2013-06-20       Impact factor: 2.916

4.  Molecular characterization of complement components (C3, C4, and factor B) in human saliva.

Authors:  A Andoh; Y Fujiyama; T Kimura; H Uchihara; H Sakumoto; H Okabe; T Bamba
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

Review 5.  The pathophysiology of IgA nephropathy.

Authors:  Hitoshi Suzuki; Krzysztof Kiryluk; Jan Novak; Zina Moldoveanu; Andrew B Herr; Matthew B Renfrow; Robert J Wyatt; Francesco Scolari; Jiri Mestecky; Ali G Gharavi; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

6.  Agaricus bisporus lectin binds mainly O-glycans but also N-glycans of human IgA subclasses.

Authors:  F J Irazoqui; F E Zalazar; G A Nores; M A Vides
Journal:  Glycoconj J       Date:  1997-04       Impact factor: 2.916

7.  Biosynthesis and secretion of MHC class III gene products (complement C4 and factor B) in the exocrine pancreas.

Authors:  K Sumiyoshi; A Andoh; Y Fujiyama; H Sakumoto; T Bamba
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

8.  Association of C4d deposition with clinical outcomes in IgA nephropathy.

Authors:  Mario Espinosa; Rosa Ortega; Marina Sánchez; Alfons Segarra; Maria Teresa Salcedo; Fayna González; Rafael Camacho; Miguel Angel Valdivia; Rocio Cabrera; Katia López; Fernando Pinedo; Eduardo Gutierrez; Alfonso Valera; Miryam Leon; Maria Angeles Cobo; Rosa Rodriguez; Jose Ballarín; Yolanda Arce; Beatriz García; María Dolores Muñoz; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

Review 9.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

10.  The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA.

Authors:  E B Nikolova; M Tomana; M W Russell
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.